{"id":"https://openalex.org/W2142016013","doi":"https://doi.org/10.1016/s1470-2045(12)70088-8","title":"Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial","display_name":"Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial","publication_year":2012,"publication_date":"2012-03-25","ids":{"openalex":"https://openalex.org/W2142016013","doi":"https://doi.org/10.1016/s1470-2045(12)70088-8","mag":"2142016013","pmid":"https://pubmed.ncbi.nlm.nih.gov/22452894","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3398767"},"language":"en","primary_location":{"id":"doi:10.1016/s1470-2045(12)70088-8","doi":"https://doi.org/10.1016/s1470-2045(12)70088-8","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1470-2045(12)70088-8","pdf_url":"http://www.thelancet.com/article/S1470204512700888/pdf","source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.thelancet.com/article/S1470204512700888/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022378006","display_name":"Nicholas David James","orcid":"https://orcid.org/0000-0002-7314-8204","observed_orcids":["https://orcid.org/0000-0002-7314-8204"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicholas D James","raw_affiliation_strings":["School of Cancer Sciences, University of Birmingham, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer Sciences, University of Birmingham, Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059261043","display_name":"Matthew Robert Sydes","orcid":"https://orcid.org/0000-0002-9323-1371","observed_orcids":["https://orcid.org/0000-0002-9323-1371"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I90344618","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210087105","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Matthew R Sydes","raw_affiliation_strings":["Medical Research Council Clinical Trials Unit, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research Council Clinical Trials Unit, London, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I90344618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032518609","display_name":"Malcolm David Mason","orcid":"https://orcid.org/0000-0003-1505-2869","observed_orcids":["https://orcid.org/0000-0003-1505-2869"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Malcolm D Mason","raw_affiliation_strings":["School of Cancer Sciences , University of Birmingham , Birmingham , UK","School of Medicine, Cardiff University, Cardiff, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer Sciences , University of Birmingham , Birmingham , UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"School of Medicine, Cardiff University, Cardiff, UK","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065195021","display_name":"Noel William Clarke","orcid":"https://orcid.org/0000-0001-7776-8059","observed_orcids":["https://orcid.org/0000-0001-7776-8059"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Noel W Clarke","raw_affiliation_strings":["School of Cancer Sciences , University of Birmingham , Birmingham , UK","Christie and Salford Royal Hospitals Foundations Trusts, and Manchester University, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer Sciences , University of Birmingham , Birmingham , UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Christie and Salford Royal Hospitals Foundations Trusts, and Manchester University, Manchester, UK","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043586804","display_name":"John Anderson","orcid":"https://orcid.org/0000-0002-2602-6079","observed_orcids":["https://orcid.org/0000-0002-2602-6079"]},"institutions":[{"id":"https://openalex.org/I2801732343","display_name":"Royal Hallamshire Hospital","ror":"https://ror.org/00514rc81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801732343","https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Anderson","raw_affiliation_strings":["Royal Hallamshire Hospital, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Hallamshire Hospital, Sheffield, UK","institution_ids":["https://openalex.org/I2801732343"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025921361","display_name":"David Paul Dearnaley","orcid":"https://orcid.org/0000-0002-3954-2806","observed_orcids":["https://orcid.org/0000-0002-3954-2806"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David P Dearnaley","raw_affiliation_strings":["School of Cancer Sciences , University of Birmingham , Birmingham , UK","Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer Sciences , University of Birmingham , Birmingham , UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105142710","display_name":"John Dwyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Dwyer","raw_affiliation_strings":["Prostate Cancer Support Federation, Stockport, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Support Federation, Stockport, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018743880","display_name":"Gordana Jovic","orcid":"https://orcid.org/0000-0002-2109-4945","observed_orcids":["https://orcid.org/0000-0002-2109-4945"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I90344618","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210087105","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gordana Jovic","raw_affiliation_strings":["Medical Research Council Clinical Trials Unit, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research Council Clinical Trials Unit, London, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I90344618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111753461","display_name":"A.W.S. Ritchie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I90344618","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210087105","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alastair WS Ritchie","raw_affiliation_strings":["Funding Cancer Research UK , Pfi zer , Novartis , Sanofi -Aventis , Medical Research Council (London , UK)","Medical Research Council Clinical Trials Unit, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Funding Cancer Research UK , Pfi zer , Novartis , Sanofi -Aventis , Medical Research Council (London , UK)","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I90344618"]},{"raw_affiliation_string":"Medical Research Council Clinical Trials Unit, London, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I90344618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007452018","display_name":"John Martin Russell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J Martin Russell","raw_affiliation_strings":["Beatson West of Scotland Cancer Centre, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beatson West of Scotland Cancer Centre, Glasgow, UK","institution_ids":["https://openalex.org/I2800373718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109931784","display_name":"Karen Sanders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I90344618","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210087105","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Karen Sanders","raw_affiliation_strings":["Medical Research Council Clinical Trials Unit, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research Council Clinical Trials Unit, London, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I90344618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030105260","display_name":"George Niklaus Thalmann","orcid":"https://orcid.org/0000-0002-1908-3286","observed_orcids":["https://orcid.org/0000-0002-1908-3286"]},"institutions":[{"id":"https://openalex.org/I2801112126","display_name":"University Hospital of Bern","ror":"https://ror.org/01q9sj412","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2801112126"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"George N Thalmann","raw_affiliation_strings":["Inselspital, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inselspital, Bern, Switzerland","institution_ids":["https://openalex.org/I2801112126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027212039","display_name":"Gianfilippo Bertelli","orcid":"https://orcid.org/0000-0002-1798-0098","observed_orcids":["https://orcid.org/0000-0002-1798-0098"]},"institutions":[{"id":"https://openalex.org/I2800526087","display_name":"Singleton Hospital","ror":"https://ror.org/02ab2dg68","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1294711689","https://openalex.org/I2800526087"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gianfilippo Bertelli","raw_affiliation_strings":["Singleton Hospital, Swansea, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Singleton Hospital, Swansea, UK","institution_ids":["https://openalex.org/I2800526087"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079820994","display_name":"Alison Jane Birtle","orcid":"https://orcid.org/0000-0002-2621-0909","observed_orcids":["https://orcid.org/0000-0002-2621-0909"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210154214","display_name":"Royal Preston Hospital","ror":"https://ror.org/05kpx1157","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1293129422","https://openalex.org/I4210154214"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alison J Birtle","raw_affiliation_strings":["School of Cancer Sciences , University of Birmingham , Birmingham , UK","Royal Preston Hospital, Preston, UK","University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer Sciences , University of Birmingham , Birmingham , UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Royal Preston Hospital, Preston, UK","institution_ids":["https://openalex.org/I4210154214"]},{"raw_affiliation_string":"University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048994559","display_name":"Joe M. O\u2019Sullivan","orcid":"https://orcid.org/0000-0001-6999-2739","observed_orcids":["https://orcid.org/0000-0001-6999-2739"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joe M O'Sullivan","raw_affiliation_strings":["School of Cancer Sciences , University of Birmingham , Birmingham , UK","Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer Sciences , University of Birmingham , Birmingham , UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062742458","display_name":"Andrew S. Protheroe","orcid":"https://orcid.org/0000-0001-9413-0575","observed_orcids":["https://orcid.org/0000-0001-9413-0575"]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Protheroe","raw_affiliation_strings":["Churchill Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Churchill Hospital, Oxford, UK","institution_ids":["https://openalex.org/I2801179840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108908651","display_name":"Denise Sheehan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4405257583","display_name":"Royal Devon University Healthcare NHS Foundation Trust","ror":"https://ror.org/05e5ahc59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4405257583"]},{"id":"https://openalex.org/I90344618","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210087105","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Denise Sheehan","raw_affiliation_strings":["Funding Cancer Research UK , Pfi zer , Novartis , Sanofi -Aventis , Medical Research Council (London , UK)","Royal Devon and Exeter, Exeter, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Funding Cancer Research UK , Pfi zer , Novartis , Sanofi -Aventis , Medical Research Council (London , UK)","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I90344618"]},{"raw_affiliation_string":"Royal Devon and Exeter, Exeter, UK","institution_ids":["https://openalex.org/I4405257583"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022329395","display_name":"Narayanan Nair Srihari","orcid":"https://orcid.org/0000-0002-3042-6067","observed_orcids":["https://orcid.org/0000-0002-3042-6067"]},"institutions":[{"id":"https://openalex.org/I4210146362","display_name":"Shrewsbury and Telford Hospital NHS Trust","ror":"https://ror.org/047feaw16","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210146362"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Narayanan Srihari","raw_affiliation_strings":["School of Cancer Sciences , University of Birmingham , Birmingham , UK","Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer Sciences , University of Birmingham , Birmingham , UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK","institution_ids":["https://openalex.org/I4210146362"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014097745","display_name":"Mahesh Parmar","orcid":"https://orcid.org/0000-0003-0166-1700","observed_orcids":["https://orcid.org/0000-0003-0166-1700","https://orcid.org/0000-0002-8883-424X"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]},{"id":"https://openalex.org/I90344618","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517","country_code":"GB","type":"government","lineage":["https://openalex.org/I4210087105","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mahesh KB Parmar","raw_affiliation_strings":["School of Cancer Sciences , University of Birmingham , Birmingham , UK","Medical Research Council Clinical Trials Unit, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer Sciences , University of Birmingham , Birmingham , UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Medical Research Council Clinical Trials Unit, London, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I90344618"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":17,"corresponding_author_ids":["https://openalex.org/A5059261043"],"corresponding_institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I90344618"],"apc_list":{"value":7280,"currency":"USD","value_usd":7280},"apc_paid":{"value":7280,"currency":"USD","value_usd":7280},"fwci":3.4512,"has_fulltext":true,"cited_by_count":125,"citation_normalized_percentile":{"value":0.92934157,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"13","issue":"5","first_page":"549","last_page":"558"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hormone-therapy","display_name":"hormone therapy","score":0.8809999823570251},{"id":"https://openalex.org/keywords/hormone-sensitive-prostate-cancer","display_name":"hormone-sensitive prostate cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/stampede-trial","display_name":"STAMPEDE trial","score":0.7459999918937683},{"id":"https://openalex.org/keywords/failure-free-survival","display_name":"failure-free survival","score":0.7590000033378601},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9390000104904175},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.753000020980835},{"id":"https://openalex.org/keywords/zoledronic-acid","display_name":"zoledronic acid","score":1.0},{"id":"https://openalex.org/keywords/prostate-specific-antigen-failure","display_name":"prostate-specific antigen failure","score":0.5189999938011169},{"id":"https://openalex.org/keywords/newly-diagnosed-prostate-cancer","display_name":"newly diagnosed prostate cancer","score":0.7049999833106995},{"id":"https://openalex.org/keywords/local-radiotherapy","display_name":"local radiotherapy","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2780275930","wikidata":"https://www.wikidata.org/wiki/Q1628266","display_name":"Hormone therapy","level":4,"score":0.7629053592681885},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6671159267425537},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6460400819778442},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.5141146779060364},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.47381559014320374},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4684814214706421},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.4573906660079956},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40493136644363403},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.32005709409713745},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3051221966743469},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.07917630672454834}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000726","descriptor_name":"Androgen Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007987","descriptor_name":"Gonadotropin-Releasing Hormone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D007987","descriptor_name":"Gonadotropin-Releasing Hormone","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009919","descriptor_name":"Orchiectomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":10,"locations":[{"id":"doi:10.1016/s1470-2045(12)70088-8","doi":"https://doi.org/10.1016/s1470-2045(12)70088-8","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1470-2045(12)70088-8","pdf_url":"http://www.thelancet.com/article/S1470204512700888/pdf","source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2403395","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3398767","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:22452894","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22452894","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet. Oncology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:3398767","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3398767/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lancet Oncol","raw_type":"Text"},{"id":"pmh:oai:boris.unibe.ch:15433","doi":null,"is_oa":false,"landing_page_url":"https://boris.unibe.ch/15433/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401086","display_name":"Bern Open Repository and Information System (University of Bern)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I118564535","host_organization_name":"University of Bern","host_organization_lineage":["https://openalex.org/I118564535"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.gla.ac.uk:84392","doi":null,"is_oa":false,"landing_page_url":"http://eprints.gla.ac.uk/84392/","pdf_url":null,"source":{"id":"https://openalex.org/S4210235606","display_name":"ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)","issn_l":"2622-8912","issn":["2622-8912","2622-8920"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/I4405259220","host_organization_name":"Institut Agama Islam Negeri Langsa","host_organization_lineage":["https://openalex.org/I4405259220"],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Articles"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1345778","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1345778/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"LANCET ONCOLOGY , 13 (5) pp. 549-558. (2012)","raw_type":"Article"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:37541","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/37541/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/58f87055-e896-49c4-ab0c-9ab50f7f37f0","doi":null,"is_oa":false,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/58f87055-e896-49c4-ab0c-9ab50f7f37f0","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:pure.qub.ac.uk/portal:publications/140d5e2c-6230-4a8a-9c0c-12cf1d2eb463","doi":null,"is_oa":false,"landing_page_url":"https://pure.qub.ac.uk/en/publications/140d5e2c-6230-4a8a-9c0c-12cf1d2eb463","pdf_url":null,"source":{"id":"https://openalex.org/S4306402319","display_name":"Research Portal (Queen's University Belfast)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126231945","host_organization_name":"Queen's University Belfast","host_organization_lineage":["https://openalex.org/I126231945"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/s1470-2045(12)70088-8","doi":"https://doi.org/10.1016/s1470-2045(12)70088-8","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1470-2045(12)70088-8","pdf_url":"http://www.thelancet.com/article/S1470204512700888/pdf","source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G2905929848","display_name":null,"funder_award_id":"10900","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G3663537095","display_name":null,"funder_award_id":"12459","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G7528670117","display_name":null,"funder_award_id":"10588","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G8573177396","display_name":null,"funder_award_id":"CRUK/06/019","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2142016013.pdf","grobid_xml":"https://content.openalex.org/works/W2142016013.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1648593433","https://openalex.org/W1981989535","https://openalex.org/W2023189718","https://openalex.org/W2028236892","https://openalex.org/W2052720577","https://openalex.org/W2060928649","https://openalex.org/W2080439368","https://openalex.org/W2103959341","https://openalex.org/W2110534364","https://openalex.org/W2117227343","https://openalex.org/W2117511763","https://openalex.org/W2117580825","https://openalex.org/W2118250868","https://openalex.org/W2118612714","https://openalex.org/W2119504728","https://openalex.org/W2120292596","https://openalex.org/W2123526148","https://openalex.org/W2132850027","https://openalex.org/W2132892424","https://openalex.org/W2138381757","https://openalex.org/W2139232028","https://openalex.org/W2139295697","https://openalex.org/W2146599397","https://openalex.org/W2148122132","https://openalex.org/W2151523134","https://openalex.org/W2151981428","https://openalex.org/W2153258256","https://openalex.org/W2155697876","https://openalex.org/W2157509061","https://openalex.org/W2158639339","https://openalex.org/W2158968701","https://openalex.org/W2165429160","https://openalex.org/W2165631552","https://openalex.org/W2165782799","https://openalex.org/W2172161665","https://openalex.org/W2336169581","https://openalex.org/W2794244580","https://openalex.org/W4211149743","https://openalex.org/W6681761019"],"related_works":["https://openalex.org/W1742267199","https://openalex.org/W2072308223","https://openalex.org/W2511094581","https://openalex.org/W2078069096","https://openalex.org/W2214621962","https://openalex.org/W2003769122","https://openalex.org/W2934971393","https://openalex.org/W2596405481","https://openalex.org/W7017751551","https://openalex.org/W2114806969"],"abstract_inverted_index":{"BACKGROUND:":[0],"Long-term":[1],"hormone":[2,58,69,76,99,282,293,329,334,497],"therapy":[3,70,77,100,106,283,294,330,335,498],"alone":[4,78,284],"is":[5,245,491],"standard":[6,110],"care":[7,111],"for":[8,101,120,328,467,486,499],"metastatic":[9],"or":[10,35,46,90,157,213,379],"high-risk,":[11],"non-metastatic":[12],"prostate":[13,93,501],"cancer.":[14],"STAMPEDE--an":[15],"international,":[16],"open-label,":[17],"randomised":[18],"controlled":[19],"trial--uses":[20],"a":[21,133,183,237],"novel":[22],"multiarm,":[23],"multistage":[24],"design":[25],"to":[26,143,270,280,291,454,488,516,528],"assess":[27,529],"whether":[28],"the":[29,63,102,176,193,223,231,264,300,304,368,476,517],"early":[30],"additional":[31],"use":[32,509],"of":[33,201,216,219,241,274,303,325,365,370,376,419,435,460,462,523],"one":[34],"two":[36],"drugs":[37],"(docetaxel,":[38],"zoledronic":[39,42,47],"acid,":[40],"celecoxib,":[41],"acid":[43,48],"and":[44,49,251,289,353,396,430,464,503,521],"docetaxel,":[45],"celecoxib)":[50],"improves":[51],"survival":[52,170,181],"in":[53,112,172,182,206,263,314,318,350,358,367,386,393,400,411,421,427,437,443,494,510],"men":[54,86],"starting":[55,97,496],"first-line,":[56],"long-term":[57,98],"therapy.":[59],"Here,":[60],"we":[61,504],"report":[62],"preplanned,":[64],"second":[65,232,305],"intermediate":[66,166,233,306],"analysis":[67,302],"comparing":[68],"plus":[71,295,331],"celecoxib":[72,147,296,332,466],"(arm":[73,297],"D)":[74,429],"with":[75,87,116,132,222,247,252,309],"(control":[79,285],"arm":[80,144,195,209,287,315,319,351,359,394,401,422,428,438,444],"A).":[81],"METHODS:":[82],"Eligible":[83],"patients":[84,123,203,260,392,420,436,468,495],"were":[85,96,189,261,277,381,414],"newly":[88,121],"diagnosed":[89,122],"rapidly":[91],"relapsing":[92],"cancer":[94],"who":[95],"first":[103],"time.":[104],"Hormone":[105],"was":[107,128,168,179,204,236,322,345,362,473],"given":[108,152],"as":[109],"all":[113,524],"trial":[114,244,265,477],"arms,":[115],"local":[117],"radiotherapy":[118],"encouraged":[119],"without":[124],"distant":[125],"metastasis.":[126],"Randomisation":[127],"done":[129],"using":[130],"minimisation":[131],"random":[134],"element":[135],"across":[136],"seven":[137],"stratification":[138],"factors.":[139],"Patients":[140],"randomly":[141,278],"allocated":[142,279],"D":[145],"received":[146],"400":[148,482],"mg":[149,483],"twice":[150,484],"daily,":[151],"orally,":[153],"until":[154],"1":[155,489],"year":[156,490],"disease":[158],"progression":[159],"(including":[160],"prostate-specific":[161],"antigen":[162],"[PSA]":[163],"failure).":[164],"The":[165,226,403,446],"outcome":[167,178],"failure-free":[169],"(FFS)":[171],"three":[173],"activity":[174,217,229,234,307],"stages;":[175],"primary":[177],"overall":[180,532],"subsequent":[184],"efficacy":[185],"stage.":[186],"Research":[187,536,542],"arms":[188,457,520,525],"compared":[190,221],"pairwise":[191],"against":[192],"control":[194,224],"on":[196,458,470,531],"an":[197,326],"intention-to-treat":[198],"basis.":[199],"Accrual":[200,513],"further":[202],"discontinued":[205],"any":[207,384],"research":[208,519],"showing":[210],"safety":[211],"concerns":[212],"insufficient":[214],"evidence":[215,324,364],"(lack":[218],"benefit)":[220],"arm.":[225],"minimum":[227],"targeted":[228],"at":[230,383],"stage":[235],"hazard":[238],"ratio":[239],"(HR)":[240],"0\u00b792.":[242],"This":[243],"registered":[246],"ClinicalTrials.gov,":[248],"number":[249,256],"NCT00268476,":[250],"Current":[253],"Controlled":[254],"Trials,":[255],"ISRCTN78818544.":[257],"FINDINGS:":[258],"2043":[259],"enrolled":[262],"from":[266],"Oct":[267],"17,":[268],"2005,":[269],"Jan":[271],"31,":[272],"2011,":[273],"whom":[275],"584":[276],"receive":[281,292],"group;":[286],"A)":[288],"291":[290],"D).":[298,402,445],"At":[299],"preplanned":[301],"stage,":[308],"305":[310],"FFS":[311,344],"events":[312,372,408],"(209":[313],"A,":[316],"96":[317],"D),":[320],"there":[321],"no":[323,363],"advantage":[327],"over":[333],"alone:":[336],"HR":[337],"0\u00b794":[338],"(95%":[339,347,355],"CI":[340,348,356,390],"0\u00b774-1\u00b720).":[341],"[corrected].":[342],"2-year":[343],"51%":[346,354],"46-56)":[349],"A":[352,395,423,439],"43-58)":[357],"D.":[360],"There":[361],"differences":[366],"incidence":[369],"adverse":[371,409],"between":[373],"groups":[374,413],"(events":[375],"grade":[377,406],"3":[378],"higher":[380],"noted":[382],"time":[385],"123":[387],"[23%,":[388],"95%":[389],"20-27]":[391],"64":[397],"[25%,":[398],"19-30]":[399],"most":[404],"common":[405],"3-5":[407],"effects":[410,530],"both":[412,455],"endocrine":[415],"disorders":[416,432],"(55":[417],"[11%]":[418],"vs":[424,440],"19":[425],"[7%]":[426],"musculoskeletal":[431],"(30":[433],"[6%]":[434,442],"15":[441],"independent":[447],"data":[448],"monitoring":[449],"committee":[450],"recommended":[451],"stopping":[452],"accrual":[453],"celecoxib-containing":[456],"grounds":[459],"lack":[461],"benefit":[463],"discontinuing":[465],"currently":[469],"treatment,":[471],"which":[472],"endorsed":[474],"by":[475],"steering":[478],"committee.":[479],"INTERPRETATION:":[480],"Celecoxib":[481],"daily":[485],"up":[487],"insufficiently":[492],"active":[493],"high-risk":[500],"cancer,":[502],"do":[505],"not":[506],"recommend":[507],"its":[508],"this":[511],"setting.":[512],"continues":[514],"seamlessly":[515],"other":[518],"follow-up":[522],"will":[526],"continue":[527],"survival.":[533],"FUNDING:":[534],"Cancer":[535],"UK,":[537],"Pfizer,":[538],"Novartis,":[539],"Sanofi-Aventis,":[540],"Medical":[541],"Council":[543],"(London,":[544],"UK).":[545]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":21},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}